Preparation and evaluation of glibenclamide-loaded biodegradable nanoparticles

Tropical Journal of Pharmaceutical Research

Volumn 11, Issue 3, 2012, Pages 345-350

  Behera, Amulyaratna ^a   Sahoo, Sunit Kumar ^a  

^a UTKAL UNIVERSITY   (India)

Author keywords

Differential scanning calorimetry; Glibenclamide; Nanoparticles; Poly (lactic co glycolic) acid; Transmission electron microscopy

Indexed keywords

DICHLOROMETHANE; GLIBENCLAMIDE; METHANOL; NANOPARTICLE; POLYGLACTIN; POLYLACTIC ACID;

ARTICLE; BIODEGRADABILITY; CONCENTRATION RESPONSE; CONTROLLED RELEASE FORMULATION; DIFFERENTIAL SCANNING CALORIMETRY; EMULSION; IN VITRO STUDY; NANOANALYSIS; NANOENCAPSULATION; NANOFABRICATION; NANOPHARMACEUTICS; PARTICLE SIZE; PHYSICAL CHEMISTRY; SUSTAINED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 84863764917     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: 10.4314/tjpr.v11i3.2     Document Type: Article

References (16)

1. Burcelin R, Eddouks M, Maury J, Kande J, Assan R, Girard J. Excessive glucose production, rather than insulin resistance, accounts for hyperglycemia in recent-onset streptozotocindiabetic rats. Diabetologies. 1995; 38: 283-290.
2. Doughlas S J, Davis S S, Illum L. Nanoparticles in Drug Delivery. Crit Rev Ther Drug Carrier Syst. 1987; 3: 233-261.
3. Trotta M, Debernard F, Caputo O. Preparation of solid-lipid NPs by a solvent emulsification diffusion technique. Int J Pharm. 2003; 257: 153-160.
4. Ye F, Shen Z, Xie M. Alpha glycosidase inhibition from a Chinese medicinal herb (Ramulus mori) in normal and diabetic rats and mice. Phytomedicine. 2002; 9: 161-166.
5. Sing S K, Verma P R, Razdan B. Glibenclamideloaded self-nanoemulsifying drug delivery system: development and characterization Drug Dev Ind Pharm. 2010; 36: 933-945.
6. Chen X, Wen H, Park K. Challenges and New Technologies of Oral Controlled Release. Oral Controlled Release Formulation, Design and Drug Delivery: Theory to Practice, Edited by Hong Wen and Kinam Park. John Wiley & Sons, Inc. 2010: 257-277.
7. Dora C P, Singh S K, Kumar S, Datusalia A K, Deep A. Development and Characterization of nanoparticles of glibenclamide by solvent displacement method. Acta Poloniae Pharmaceutica and Drug Research. 2010; 67: 283-290.
8. Arnqvist HJ, Karlberg BE, Melander A. Pharmacokinetics and effects of glibenclamide in two formulations, HB 419 and HB 420, in type 2 diabetes. Ann Clin Res. 1983; 37:21-25.
9. Chalk J.B., Patterson M., Smith M.T., Eadie M.J. Correlations between in vitro dissolution, in vivo bioavailability and hypoglycaemic effect of oral glibenclamide. Eur J Clin Pharmacol. 1986;31:177-82.
10. Kaplani A P, Malamataris S. Preparation and characterisation of a new insoluble polymorphic form of glibenclamide. International Journal of Pharmaceutics. 2000;195: 239-246.
11. Ganley J.A., McEven J., Calvert R.T., Barker C.J.: The effect of in-vivo dispersion and gastric emptying on glibenclamide absorption from a novel, rapidly dissolving capsule formulation. J. Pharm. Pharmacol. 1984;36:734-739.
12. Salem M S, Najib N M, Hassan M A, Suleiman M S. Dissolution kinetics of glibenclamide glass. Acta Pharm. Hung. 1997;67:13-17.
13. Devarajan PV, Sonavane GS. Preparation and in vitro/in vivo evaluation of gliclazide loaded eudragit NPs as sustained release carriers. Drug Dev Ind Pharm. 2007; 33:101-11.
14. Cui F, Shi K, Zhang L, Tao A, Kawashima Y. Biodegradable NPs loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation. J Control Release. 2006; 114: 242-250.
15. Guyot M, Fawaz F. Nifedipine loaded polymeric microspheres: preparation and physical characterization. Int J Pharm. 1998; 175: 61-74.
16. Paulo C, Jose M. Modeling and comparision of dissolution profiles, Eur J Pharm Sci. 2001; 13: 123-133.